Cargando…
The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study
Background: Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk of developing psychosis and cognitive impairments, which may be related to dopaminergic and glutamatergic abnormalities. Therefore, in this exploratory study, we examined the association between dopaminergic and g...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498700/ https://www.ncbi.nlm.nih.gov/pubmed/36140839 http://dx.doi.org/10.3390/genes13091672 |
_version_ | 1784794825129721856 |
---|---|
author | van Hooijdonk, Carmen F. M. Tse, Desmond H. Y. Roosenschoon, Julia Ceccarini, Jenny Booij, Jan van Amelsvoort, Therese A. M. J. Vingerhoets, Claudia |
author_facet | van Hooijdonk, Carmen F. M. Tse, Desmond H. Y. Roosenschoon, Julia Ceccarini, Jenny Booij, Jan van Amelsvoort, Therese A. M. J. Vingerhoets, Claudia |
author_sort | van Hooijdonk, Carmen F. M. |
collection | PubMed |
description | Background: Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk of developing psychosis and cognitive impairments, which may be related to dopaminergic and glutamatergic abnormalities. Therefore, in this exploratory study, we examined the association between dopaminergic and glutamatergic functioning in 22q11DS. Additionally, the associations between glutamatergic functioning and brain volumes in 22q11DS and healthy controls (HC), as well as those between dopaminergic and cognitive functioning in 22q11DS, were also examined. Methods: In this cross-sectional, multimodal imaging study, glutamate, glutamine, and their combined concentration (Glx) were assessed in the anterior cingulate cortex (ACC) and striatum in 17 22q11DS patients and 20 HC using 7T proton magnetic resonance spectroscopy. Ten 22q11DS patients also underwent (18)F-fallypride positron emission tomography to measure dopamine D(2/3) receptor (D(2/3)R) availability in the ACC and striatum. Cognitive performance was assessed with the Cambridge Neuropsychological Test Automated Battery. Results: No significant associations were found between ACC or striatal (1) glutamate, glutamine, or Glx concentrations and (2) D(2/3)R availability. In HC but not in 22q11DS patients, we found a significant relationship between ACC volume and ACC glutamate, glutamine, and Glx concentration. In addition, some aspects of cognitive functioning were significantly associated with D(2/3)R availability in 22q11DS. However, none of the associations remained significant after Bonferroni correction. Conclusions: Although our results did not reach statistical significance, our findings suggest an association between glutamatergic functioning and brain volume in HC but not in 22q11DS. Additionally, D(2/3)R availability seems to be related to cognitive functioning in 22q11DS. Studies in larger samples are needed to further elucidate our findings. |
format | Online Article Text |
id | pubmed-9498700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94987002022-09-23 The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study van Hooijdonk, Carmen F. M. Tse, Desmond H. Y. Roosenschoon, Julia Ceccarini, Jenny Booij, Jan van Amelsvoort, Therese A. M. J. Vingerhoets, Claudia Genes (Basel) Article Background: Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk of developing psychosis and cognitive impairments, which may be related to dopaminergic and glutamatergic abnormalities. Therefore, in this exploratory study, we examined the association between dopaminergic and glutamatergic functioning in 22q11DS. Additionally, the associations between glutamatergic functioning and brain volumes in 22q11DS and healthy controls (HC), as well as those between dopaminergic and cognitive functioning in 22q11DS, were also examined. Methods: In this cross-sectional, multimodal imaging study, glutamate, glutamine, and their combined concentration (Glx) were assessed in the anterior cingulate cortex (ACC) and striatum in 17 22q11DS patients and 20 HC using 7T proton magnetic resonance spectroscopy. Ten 22q11DS patients also underwent (18)F-fallypride positron emission tomography to measure dopamine D(2/3) receptor (D(2/3)R) availability in the ACC and striatum. Cognitive performance was assessed with the Cambridge Neuropsychological Test Automated Battery. Results: No significant associations were found between ACC or striatal (1) glutamate, glutamine, or Glx concentrations and (2) D(2/3)R availability. In HC but not in 22q11DS patients, we found a significant relationship between ACC volume and ACC glutamate, glutamine, and Glx concentration. In addition, some aspects of cognitive functioning were significantly associated with D(2/3)R availability in 22q11DS. However, none of the associations remained significant after Bonferroni correction. Conclusions: Although our results did not reach statistical significance, our findings suggest an association between glutamatergic functioning and brain volume in HC but not in 22q11DS. Additionally, D(2/3)R availability seems to be related to cognitive functioning in 22q11DS. Studies in larger samples are needed to further elucidate our findings. MDPI 2022-09-19 /pmc/articles/PMC9498700/ /pubmed/36140839 http://dx.doi.org/10.3390/genes13091672 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article van Hooijdonk, Carmen F. M. Tse, Desmond H. Y. Roosenschoon, Julia Ceccarini, Jenny Booij, Jan van Amelsvoort, Therese A. M. J. Vingerhoets, Claudia The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study |
title | The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study |
title_full | The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study |
title_fullStr | The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study |
title_full_unstemmed | The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study |
title_short | The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study |
title_sort | relationships between dopaminergic, glutamatergic, and cognitive functioning in 22q11.2 deletion syndrome: a cross-sectional, multimodal (1)h-mrs and (18)f-fallypride pet study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498700/ https://www.ncbi.nlm.nih.gov/pubmed/36140839 http://dx.doi.org/10.3390/genes13091672 |
work_keys_str_mv | AT vanhooijdonkcarmenfm therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT tsedesmondhy therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT roosenschoonjulia therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT ceccarinijenny therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT booijjan therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT vanamelsvoortthereseamj therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT vingerhoetsclaudia therelationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT vanhooijdonkcarmenfm relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT tsedesmondhy relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT roosenschoonjulia relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT ceccarinijenny relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT booijjan relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT vanamelsvoortthereseamj relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy AT vingerhoetsclaudia relationshipsbetweendopaminergicglutamatergicandcognitivefunctioningin22q112deletionsyndromeacrosssectionalmultimodal1hmrsand18ffallypridepetstudy |